CAD 0.01
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -10.03 Million CAD | -91.75% |
2022 | -13.83 Million CAD | -23.85% |
2021 | -2.7 Million CAD | 83.88% |
2020 | -14.26 Million CAD | -55.02% |
2019 | -16.2 Million CAD | -214.98% |
2018 | -2.86 Million CAD | -25.75% |
2017 | -2.53 Million CAD | 35.97% |
2016 | -1.97 Million CAD | -8897.33% |
2015 | - CAD | 0.0% |
2013 | -1.03 Million CAD | 996.97% |
2012 | -210.41 Thousand CAD | 83.08% |
2011 | -567.06 Thousand CAD | -273.57% |
2010 | -151.79 Thousand CAD | -148.55% |
2009 | -61.07 Thousand CAD | -105.55% |
2008 | -29.71 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q3 | 289.75 Thousand CAD | 526.78% |
2024 Q2 | 1.13 Million CAD | -59.14% |
2024 Q1 | 484.66 Thousand CAD | 105.76% |
2023 FY | - CAD | -91.75% |
2023 Q1 | 161.43 Thousand CAD | 105.84% |
2023 Q2 | 140.65 Thousand CAD | -12.87% |
2023 Q3 | -2.87 Million CAD | -2141.39% |
2023 Q4 | -2.6 Million CAD | 9.18% |
2022 Q1 | -111.94 Thousand CAD | 93.28% |
2022 FY | - CAD | -23.85% |
2022 Q3 | 406.98 Thousand CAD | 197.85% |
2022 Q4 | -2.76 Million CAD | -779.1% |
2022 Q2 | -415.92 Thousand CAD | -271.56% |
2021 Q4 | -1.66 Million CAD | -212.99% |
2021 Q3 | 1.47 Million CAD | 379.4% |
2021 FY | - CAD | 83.88% |
2021 Q2 | -527.51 Thousand CAD | 67.24% |
2021 Q1 | -1.61 Million CAD | 57.07% |
2020 FY | - CAD | -55.02% |
2020 Q1 | -2.38 Million CAD | 10.93% |
2020 Q2 | -5.05 Million CAD | -112.32% |
2020 Q3 | -3.25 Million CAD | 35.65% |
2020 Q4 | -3.75 Million CAD | -15.23% |
2019 Q2 | -1.51 Million CAD | 32.47% |
2019 Q4 | -2.67 Million CAD | 10.25% |
2019 FY | - CAD | -214.98% |
2019 Q1 | -2.23 Million CAD | -23.94% |
2019 Q3 | -2.98 Million CAD | -97.08% |
2018 Q1 | -420.81 Thousand CAD | 74.42% |
2018 FY | - CAD | -25.75% |
2018 Q4 | -1.8 Million CAD | -743.2% |
2018 Q3 | -214.26 Thousand CAD | 58.56% |
2018 Q2 | -517 Thousand CAD | -22.86% |
2017 Q1 | -113.29 Thousand CAD | 94.03% |
2017 Q4 | -1.64 Million CAD | -201.36% |
2017 FY | - CAD | 35.97% |
2017 Q3 | -545.98 Thousand CAD | -128.36% |
2017 Q2 | -239.09 Thousand CAD | -111.04% |
2016 Q2 | -722.81 Thousand CAD | -284.44% |
2016 Q1 | -188.01 Thousand CAD | -385.89% |
2016 FY | - CAD | -8897.33% |
2016 Q4 | -1.89 Million CAD | -721.84% |
2016 Q3 | -230.75 Thousand CAD | 68.08% |
2015 Q4 | -38.69 Thousand CAD | 33.32% |
2015 FY | - CAD | 0.0% |
2015 Q3 | -58.03 Thousand CAD | -166.91% |
2015 Q2 | -21.74 Thousand CAD | -151.36% |
2015 Q1 | -8650.00 CAD | 82.23% |
2014 Q3 | -16.45 Thousand CAD | -101.8% |
2014 Q4 | -48.69 Thousand CAD | -195.83% |
2014 Q1 | -16.61 Thousand CAD | -49.42% |
2014 Q2 | 915.94 Thousand CAD | 5613.06% |
2013 Q3 | -27.46 Thousand CAD | 52.9% |
2013 Q4 | -11.11 Thousand CAD | 59.51% |
2013 FY | - CAD | 996.97% |
2013 Q1 | -39.33 Thousand CAD | -61.58% |
2013 Q2 | -58.3 Thousand CAD | -48.23% |
2012 Q4 | -24.34 Thousand CAD | 21.98% |
2012 Q1 | -52.46 Thousand CAD | 49.37% |
2012 Q2 | -188.18 Thousand CAD | -258.68% |
2012 Q3 | -31.2 Thousand CAD | 83.42% |
2012 FY | - CAD | 83.08% |
2011 Q2 | -97.04 Thousand CAD | -169.05% |
2011 Q4 | -103.63 Thousand CAD | 53.48% |
2011 Q3 | -222.77 Thousand CAD | -129.56% |
2011 FY | - CAD | -273.57% |
2011 Q1 | -36.06 Thousand CAD | -343.82% |
2010 Q2 | -23.5 Thousand CAD | -12.69% |
2010 FY | - CAD | -148.55% |
2010 Q4 | -8127.00 CAD | 24.51% |
2010 Q3 | -10.76 Thousand CAD | 54.21% |
2010 Q1 | -20.85 Thousand CAD | -248.87% |
2009 Q1 | -17.5 Thousand CAD | 0.0% |
2009 Q4 | -5979.00 CAD | 44.26% |
2009 Q3 | -10.72 Thousand CAD | 0.0% |
2009 FY | - CAD | -105.55% |
2008 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Aion Therapeutic Inc. | -6.07 Million CAD | -65.187% |
Ayurcann Holdings Corp. | -2.01 Million CAD | -399.03% |
Blueberries Medical Corp. | -1.22 Million CAD | -721.169% |
The BC Bud Corporation | -1.19 Million CAD | -738.866% |
BioNxt Solutions Inc. | -6.48 Million CAD | -54.719% |
CordovaCann Corp. | -1.6 Million CAD | -526.035% |
Christina Lake Cannabis Corp. | -2.62 Million CAD | -282.433% |
Captor Capital Corp. | 2.42 Million CAD | 514.385% |
City View Green Holdings Inc. | -2.01 Million CAD | -398.047% |
1CM Inc. | 1.31 Million CAD | 863.818% |
Global Hemp Group Inc. | -24.79 Thousand CAD | -40366.882% |
Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -354.31% |
IM Cannabis Corp. | -2.79 Million CAD | -259.604% |
Lobe Sciences Ltd. | -4.4 Million CAD | -127.903% |
Maple Leaf Green World Inc. | -392.21 Thousand CAD | -2458.018% |
Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -214.217% |
Nextleaf Solutions Ltd. | 1.14 Million CAD | 978.849% |
Ovation Science Inc. | -778.83 Thousand CAD | -1188.205% |
Pharmadrug Inc. | -1.33 Million CAD | -651.525% |
Captiva Verde Wellness Corp. | -6.05 Million CAD | -65.667% |
RAMM Pharma Corp. | -6.3 Million CAD | -59.2% |
RIV Capital Inc. | -20.28 Million CAD | 50.529% |
Revive Therapeutics Ltd. | -5.59 Million CAD | -79.32% |
Red White & Bloom Brands Inc. | -77.59 Million CAD | 87.069% |
SLANG Worldwide Inc. | -2.95 Million CAD | -240.017% |
Red Light Holland Corp. | -5.25 Million CAD | -90.891% |
Top Strike Resources Corp. | -767.99 Thousand CAD | -1206.386% |
Xebra Brands Ltd. | -1.49 Million CAD | -571.102% |
Adastra Holdings Ltd. | -1.41 Million CAD | -610.92% |